{
    "id": 1045,
    "fullName": "RAD51 wild-type",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "Wild-type RAD51 indicates that no mutations have been detected within the RAD51 gene.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 5888,
        "geneSymbol": "RAD51",
        "terms": [
            "RAD51",
            "BRCC5",
            "FANCR",
            "HRAD51",
            "HsRad51",
            "HsT16930",
            "MRMV2",
            "RAD51A",
            "RECA"
        ]
    },
    "variant": "wild-type",
    "createDate": "07/17/2014",
    "updateDate": "05/15/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 1608,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, RI-1 inhibited the activity of Rad51, resulting in increased sensitivity of tumor cells to DNA damaging agents in culture and increased cell death (PMID: 22573178).",
            "molecularProfile": {
                "id": 1100,
                "profileName": "RAD51 wild-type"
            },
            "therapy": {
                "id": 1934,
                "therapyName": "RI-1",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 1640,
                    "pubMedId": 22573178,
                    "title": "RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22573178"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 1100,
            "profileName": "RAD51 wild-type",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}